Maxim Group Maintains Buy on Nutex Health, Lowers Price Target to $205

Benzinga · 08/26/2025 15:57
Maxim Group analyst Anthony Vendetti maintains Nutex Health (NASDAQ:NUTX) with a Buy and lowers the price target from $225 to $205.